Doria Mattia, Careddu Domenico, Iorio Raffaele, Verrotti Alberto, Chiappini Elena, Barbero Giulio Michele, Ceschin Flavia, Dell'Era Laura, Fabiano Valentina, Mencacci Michele, Carlomagno Francesco, Libranti Maria, Mazzone Teresa, Vitale Antonio
Italian Pediatricians Federation (FIMP), 30015 Chioggia, Italy.
Italian Pediatricians Federation (FIMP), 28100 Novara, Italy.
Children (Basel). 2021 Sep 30;8(10):873. doi: 10.3390/children8100873.
Fever and pain are challenging symptoms in children and adolescents and are common reasons for consultations in primary care and hospital. Paracetamol and ibuprofen are currently the only recommended drugs for treating fever in Italy, but the therapeutic approaches are discrepant in the different settings. In Italy, paracetamol and ibuprofen are the most prescribed analgesics for acute mild-moderate pain in children; however, their use is often inappropriate in that fever is over-treated and pain is under-treated. An Italian board of experts analyzed the motivations for the misalignment between daily practice and guidelines of fever and acute mild-moderate pain management of the territory and hospitals. The expert opinion consensus process underscored the appropriate use of paracetamol and ibuprofen according to clinical scenarios, patients' profiles, and the safety features of the drugs. Although patients' profiles can indicate different benefits from paracetamol or ibuprofen, critical issues of fever and acute mild-moderate pain management persist in primary care and hospitals. These expert opinion consensus statements can be an across-the-board tool to harmonize the routine practice between the territory and hospitals, especially under special conditions (at-risk for dehydration, coagulation disorder patients, etc.). It can also promote educational activity about fever and acute mild-moderate pain management to enhance the milestones already achieved by Italian pediatricians.
发热和疼痛是儿童及青少年面临的具有挑战性的症状,也是基层医疗和医院会诊的常见原因。对乙酰氨基酚和布洛芬是目前意大利唯一推荐用于治疗发热的药物,但在不同环境下的治疗方法存在差异。在意大利,对乙酰氨基酚和布洛芬是儿童急性轻至中度疼痛最常用的镇痛药;然而,它们的使用往往并不恰当,因为发热治疗过度而疼痛治疗不足。一个意大利专家委员会分析了该地区和医院在发热及急性轻至中度疼痛管理方面日常实践与指南不一致的原因。专家意见共识过程强调应根据临床情况、患者情况以及药物的安全特性合理使用对乙酰氨基酚和布洛芬。尽管患者情况可能表明对乙酰氨基酚或布洛芬有不同的益处,但基层医疗和医院在发热及急性轻至中度疼痛管理方面的关键问题依然存在。这些专家意见共识声明可以成为协调该地区和医院常规实践的全面工具,尤其是在特殊情况下(有脱水风险、凝血障碍患者等)。它还可以促进关于发热及急性轻至中度疼痛管理的教育活动,以巩固意大利儿科医生已经取得的成果。